Literature DB >> 25270050

Clinico-pathological manifestations of variant late infantile neuronal ceroid lipofuscinosis (vLINCL) caused by a novel mutation in MFSD8 gene.

Hanna Mandel1, Ksenya Cohen Katsanelson2, Morad Khayat3, Ilana Chervinsky4, Eugene Vladovski5, Theodor C Iancu6, Margarita Indelman7, Yoseph Horovitz8, Eli Sprecher9, Stavit A Shalev3, Ronen Spiegel10.   

Abstract

Neuronal ceroid lipofuscinosis (NCL) refers to a growing heterogeneous group of neurodegenerative disorders characterized by lysosomal accumulation of abnormal autofluorescent material. NCLs are traditionally classified clinically according to their age of onset. Variable late infantile NCL (vLINCL) is the most genetically heterogeneous subtype as it has been shown to be caused by mutations in at least six genes. We report on 5 patients of a consanguineous family who presented in early childhood with intractable seizures, severe cognitive and motor decline, behavioral impairment and progressive retinal degeneration. Disease course was severe; all patients were in a vegetative state by the second decade of life, and eventually die prematurely (except in one case). Ultrastructural studies of brain and rectal mucosa disclosed accumulation of storage material in various patterns including fingerprint, curvilinear, and granular osmiophilic deposits consistent with the diagnosis of NCL. Brain pathologic features from a living patient are first reported here and shed light on disease progression and pathogenesis. Using a combination of whole genome autozygosity mapping and candidate gene direct sequencing, we identified a mutation in MFSD8, c.472G>A (p.Gly158Ser), which was found to segregate with the disease phenotype in the family. This study underscores the importance of a combined clinic-molecular workup in NCLs and other neurodegenerative conditions.
Copyright © 2014 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Autosomal recessive; Lysosomal storage; Neuronal ceroid lipofuscinosis; Retinal degeneration

Mesh:

Substances:

Year:  2014        PMID: 25270050     DOI: 10.1016/j.ejmg.2014.09.004

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  10 in total

1.  Rare variants in the neuronal ceroid lipofuscinosis gene MFSD8 are candidate risk factors for frontotemporal dementia.

Authors:  Ethan G Geier; Mathieu Bourdenx; Nadia J Storm; J Nicholas Cochran; Daniel W Sirkis; Ji-Hye Hwang; Luke W Bonham; Eliana Marisa Ramos; Antonio Diaz; Victoria Van Berlo; Deepika Dokuru; Alissa L Nana; Anna Karydas; Maureen E Balestra; Yadong Huang; Silvia P Russo; Salvatore Spina; Lea T Grinberg; William W Seeley; Richard M Myers; Bruce L Miller; Giovanni Coppola; Suzee E Lee; Ana Maria Cuervo; Jennifer S Yokoyama
Journal:  Acta Neuropathol       Date:  2018-10-31       Impact factor: 17.088

Review 2.  Myoclonus-Ataxia Syndromes: A Diagnostic Approach.

Authors:  Malco Rossi; Sterre van der Veen; Marcelo Merello; Marina A J Tijssen; Bart van de Warrenburg
Journal:  Mov Disord Clin Pract       Date:  2020-11-03

3.  Loss of CLN7 results in depletion of soluble lysosomal proteins and impaired mTOR reactivation.

Authors:  Tatyana Danyukova; Khandsuren Ariunbat; Melanie Thelen; Nahal Brocke-Ahmadinejad; Sara E Mole; Stephan Storch
Journal:  Hum Mol Genet       Date:  2018-05-15       Impact factor: 6.150

4.  Next-generation sequencing identifies unexpected genotype-phenotype correlations in patients with retinitis pigmentosa.

Authors:  Johannes Birtel; Martin Gliem; Elisabeth Mangold; Philipp L Müller; Frank G Holz; Christine Neuhaus; Steffen Lenzner; Diana Zahnleiter; Christian Betz; Tobias Eisenberger; Hanno J Bolz; Peter Charbel Issa
Journal:  PLoS One       Date:  2018-12-13       Impact factor: 3.240

5.  Functional characterization of novel MFSD8 pathogenic variants anticipates neurological involvement in juvenile isolated maculopathy.

Authors:  Miriam Bauwens; Stephan Storch; Nicole Weisschuh; Chantal Ceuterick-de Groote; Riet De Rycke; Brecht Guillemyn; Sarah De Jaegere; Frauke Coppieters; Rudy Van Coster; Bart P Leroy; Elfride De Baere
Journal:  Clin Genet       Date:  2019-12-12       Impact factor: 4.438

6.  A Novel, Apparently Silent Variant in MFSD8 Causes Neuronal Ceroid Lipofuscinosis with Marked Intrafamilial Variability.

Authors:  Milda Reith; Lena Zeltner; Karin Schäferhoff; Dennis Witt; Theresia Zuleger; Tobias B Haack; Antje Bornemann; Michael Alber; Susanne Ruf; Ludger Schoels; Katarina Stingl; Nicole Weisschuh
Journal:  Int J Mol Sci       Date:  2022-02-18       Impact factor: 5.923

7.  AAV9/MFSD8 gene therapy is effective in preclinical models of neuronal ceroid lipofuscinosis type 7 disease.

Authors:  Xin Chen; Thomas Dong; Yuhui Hu; Frances C Shaffo; Nandkishore R Belur; Joseph R Mazzulli; Steven J Gray
Journal:  J Clin Invest       Date:  2022-03-01       Impact factor: 14.808

8.  Contribution of Whole-Genome Sequencing and Transcript Analysis to Decipher Retinal Diseases Associated with MFSD8 Variants.

Authors:  Anaïs F Poncet; Olivier Grunewald; Veronika Vaclavik; Isabelle Meunier; Isabelle Drumare; Valérie Pelletier; Béatrice Bocquet; Margarita G Todorova; Anne-Gaëlle Le Moing; Aurore Devos; Daniel F Schorderet; Florence Jobic; Sabine Defoort-Dhellemmes; Hélène Dollfus; Vasily M Smirnov; Claire-Marie Dhaenens
Journal:  Int J Mol Sci       Date:  2022-04-13       Impact factor: 6.208

9.  CLN7/MFSD8 may be an important factor for SARS-CoV-2 cell entry.

Authors:  Elena-Sofia Heinl; Sebastian Lorenz; Barbara Schmidt; Nouf Nasser M Laqtom; Joseph R Mazzulli; Laetitia Francelle; Timothy W Yu; Benjamin Greenberg; Stephan Storch; Ines Tegtmeier; Helga Othmen; Katja Maurer; Malin Steinfurth; Ralph Witzgall; Vladimir Milenkovic; Christian H Wetzel; Markus Reichold
Journal:  iScience       Date:  2022-09-06

10.  A novel MFSD8 mutation in a Russian patient with neuronal ceroid lipofuscinosis type 7: a case report.

Authors:  Anastasiya Aleksandrovna Kozina; Elena Grigorievna Okuneva; Natalia Vladimirovna Baryshnikova; Anna Yurievna Krasnenko; Kirill Yurievich Tsukanov; Olesya Igorevna Klimchuk; Olga Borisovna Kondakova; Anna Nikolaevna Larionova; Tatyana Timofeevna Batysheva; Ekaterina Ivanovna Surkova; Peter Alekseevich Shatalov; Valery Vladimirovich Ilinsky
Journal:  BMC Med Genet       Date:  2018-08-25       Impact factor: 2.103

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.